Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder maintains an Underweight rating on Nevro (NYSE:NVRO) and has lowered the price target from $24 to $15.
November 02, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained an Underweight rating on Nevro and lowered the price target from $24 to $15, which could negatively impact the stock's price.
The lowering of the price target by Piper Sandler from $24 to $15 indicates a bearish outlook for Nevro. This could lead to a decrease in the stock's price as it suggests that the analyst believes the stock is currently overvalued. The Underweight rating also suggests that the analyst recommends investors to underweight Nevro in their portfolios, which could lead to selling pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100